The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
HER2 status in locally advanced rectal cancer and metachronous metastases: Opportunity for a new therapeutic approach?
Lena-Christin Conradi
No relevant relationships to disclose
Hanna Styczen
No relevant relationships to disclose
Thilo Sprenger
No relevant relationships to disclose
Kia Homayounfar
No relevant relationships to disclose
Hendrik A. Wolff
No relevant relationships to disclose
Annalen Bleckmann
No relevant relationships to disclose
Josef Rüschoff
No relevant relationships to disclose
Peter Middel
No relevant relationships to disclose
Heinz Becker
No relevant relationships to disclose
B. Michael Ghadimi
No relevant relationships to disclose
Tim Beissbarth
No relevant relationships to disclose
Torsten Liersch
No relevant relationships to disclose